FLT3-IN-3

FLT3-IN-3 Suppliers list
Company Name: Shanghai Lollane Biological Technology Co.,Ltd.  
Tel: 021-52996696,15000506266 15000506266
Email:
Company Name: Shanghai Beckham Medical Technology Co., Ltd  
Tel: 13816613772
Email: huahero21@sina.com
Company Name: Shanghai EFE Biological Technology Co., Ltd.  
Tel: 021-65675885 18964387627
Email: info@efebio.com
Company Name: Shanghai YuanYe Biotechnology Co., Ltd.  
Tel: 15026964105
Email: 2881489226@qq.com
Company Name: Tianjin Kailiqi Biotechnology Co., Ltd.  
Tel: 15076683720
Email: klq@cw-bio.com

FLT3-IN-3 manufacturers

  • FLT3-IN-3
  • FLT3-IN-3 pictures
  • $109.00
  • 2026-07-27
  • CAS:2229050-90-0
  • Purity: 99.97%
  • Supply Ability: 10g
  • FLT3-IN-3
  • FLT3-IN-3 pictures
  • $109.00
  • 2026-07-14
  • CAS:2229050-90-0
  • Purity: 99.97%
  • Supply Ability: 10g
FLT3-IN-3 Basic information
Product Name:FLT3-IN-3
Synonyms:FLT3-IN-3;9H-Purine-2,6-diamine, N2-(trans-4-aminocyclohexyl)-9-cyclopentyl-N6-[4-(4-morpholinylmethyl)phenyl]-;SAN50900;inhibit,Fms like tyrosine kinase 3,FLT-3-IN-3,FLT3,CD135,Inhibitor,Cluster of differentiation antigen 135,FLT3IN3,FLT3 IN 3;N2-(trans-4-Aminocyclohexyl)-9-cyclopentyl-N6-(4-(morpholinomethyl)phenyl)-9H-purine-2,6-diamine;9-cyclopentyl-N6-{4-[(morpholin-4-yl)methyl]phenyl}-N2-[(1r,4r)-4-aminocyclohexyl]-9H-purine-2,6-diamine;FLT3-IN-3, 10 mM in DMSO
CAS:2229050-90-0
MF:C27H38N8O
MW:490.64
EINECS:
Product Categories:
Mol File:2229050-90-0.mol
FLT3-IN-3 Structure
FLT3-IN-3 Chemical Properties
Melting point 133-135 °C
Boiling point 717.6±70.0 °C(Predicted)
density 1.42±0.1 g/cm3(Predicted)
storage temp. Store at -20°C
solubility DMF: 10 mg/ml; DMSO: 10 mg/ml; Ethanol: 15 mg/ml; PBS (pH 7.2): insol
form A solid
pka10.42±0.70(Predicted)
color White to off-white
Safety Information
MSDS Information
FLT3-IN-3 Usage And Synthesis
UsesFLT3-IN-3 is a potent FLT3 inhibitor with IC50s of 13 and 8 nM for FLT3 WT and FLT3 D835Y, respectively.
in vivo

A single dose of FLT3-IN-3 (Compound 7d; 10 mg/kg; i.p.) in mice with subcutaneous MV4-11 xenografts causes sustained inhibition of FLT3 and STAT5 phosphorylation over 48 hours[1].

Animal Model:Female athymic nu/nu mice with subcutaneously implanted MV4-11 xenografts[1]
Dosage:10 mg/kg
Administration:Intraperitoneal (i.p.) injection; 48 hours
Result:Effectively inhibited FLT3-ITD autophosphorylation in MV4-11 xenografts.
References[1] Gucky T, et al. Discovery of N2-(4-Amino-cyclohexyl)-9-cyclopentyl- N6-(4-morpholin-4-ylmethyl-phenyl)- 9H-purine-2,6-diamine as a Potent FLT3 Kinase Inhibitor for Acute Myeloid Leukemia with FLT3 Mutations. J Med Chem. 2018 May 10;61(9):3855-3869. DOI:10.1021/acs.jmedchem.7b01529
FLT3-IN-3 Preparation Products And Raw materials
Tag:FLT3-IN-3(2229050-90-0) Related Product Information
TCS 359 SB1317 KGWWHPZQLVVAPT-STTJLUEPSA-N R-1530 1-[(3R)-3-[4-Amino-3-(4-phenoxyphenyl)-1H-pyrazolo[3,4-d]pyrimidin-1-yl]-1-piperidinyl]-2-(dimethylamino)-ethanone FLT3 Protein, HUMAN (T227M, HEK293, HIS)